NCT07602049 Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma Status RECRUITING Phase PHASE2
NCT07593573 the Exploration of MTAP Deletion in Osteosarcoma by Immunohistochemistry Status ACTIVE_NOT_RECRUITING Phase N/A
NCT07516353 my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults Status NOT_YET_RECRUITING Phase NA
NCT07514819 Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma Status NOT_YET_RECRUITING Phase NA
NCT07479732 Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma Status RECRUITING Phase PHASE1/PHASE2
NCT07477457 A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With Osteosarcoma Status RECRUITING Phase PHASE2
NCT07321912 Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07215728 Machine Learning Applied to EHRs Data of Patients With Sarcoma Status COMPLETED Phase N/A
NCT07142863 Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients Status NOT_YET_RECRUITING Phase PHASE2
NCT07052383 Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas Status RECRUITING Phase PHASE1
NCT06935409 Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment Failure Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06850506 Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06776198 Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study Status NOT_YET_RECRUITING Phase N/A
NCT06726512 Quantitative Margin Assessment Using High-resolution Positron Emission Tomography - Computed Tomograhy Status NOT_YET_RECRUITING Phase NA
NCT06714383 Trilaciclib Combing Chemotherapy in the Neoadjuvant Treatment of Osteosarcoma Status RECRUITING Phase PHASE2
NCT06709495 Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas Status RECRUITING Phase PHASE1/PHASE2
NCT06699576 ARTEMIS-103: Phase 1b Study of HS-20093 Combinations in Patients with Bone and Soft Tissue Sarcoma. Status NOT_YET_RECRUITING Phase PHASE1
NCT06650514 A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma Status RECRUITING Phase PHASE2